Lung SBRT
Feasibility Study on Deformable Image Registration for Lung SBRT Patients for Dose Driven Adaptive Therapy
9
MRI-guided lung SBRT: Present and future developments.
11
Real-time 4D dose reconstruction for tracked dynamic MLC deliveries for lung SBRT.
11
Lung SBRT through Radiobiology
10
Dosimetric Comparisons of Lung SBRT with Multiple Metastases by Two Advanced Planning Systems
11
Dose prescription with spatial uncertainty for peripheral lung SBRT.
8
<p>Efficacy and tolerability of stereotactic body radiotherapy for lung metastases in three patients with pediatric malignancies</p>
5
PubMedCentral-PMC5541363.pdf
16
Dosimetric Comparison of Different Prescription Modes in Lung Stereotactic Body Radiation Therapy
6
Comparison of Stereotactic Body Radiotherapy Delivery Techniques for Early Stage Lung Cancer Using Lung Toxicity Modeling
14
Dosimetric comparison of peripheral NSCLC SBRT using Acuros XB and AAA calculation algorithms
17
An Integrated Simulation System Based on Digital Human Phantom for 4D Radiation Therapy of Lung Cancer
11
Dosimetric Impact of Tumor Position and Lung Density Variations in Lung Stereotactic Body Radiotherapy
6
Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives
11
A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy
8
Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer
11
Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer
15
Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database
10
<p>Dosimetric comparison of different algorithms in stereotactic body radiation therapy (SBRT) plan for non-small cell lung cancer (NSCLC)</p>
7
1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT
7